Class information for:
Level 2: EFAVIRENZ//NEVIRAPINE//RALTEGRAVIR

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
773 12242 34.5 78%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
7 4 INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY 1353914
29 3       HIV//VIROLOGY//HIV 1 108954
773 2             EFAVIRENZ//NEVIRAPINE//RALTEGRAVIR 12242
545 1                   HIV DRUG RESISTANCE//HIV 1 DRUG RESISTANCE//TRANSMITTED DRUG RESISTANCE 3324
2183 1                   HIV 1 PROTEASE//HIV PROTEASE//HIV 1 PROTEASE INHIBITORS 2330
5405 1                   ZIDOVUDINE//DIDANOSINE//ZALCITABINE 1627
6181 1                   ATAZANAVIR//RITONAVIR//LOPINAVIR 1517
7021 1                   RALTEGRAVIR//DOLUTEGRAVIR//ETRAVIRINE 1415
11702 1                   I TECH SERV//LAMIVUDINE//EMTRICITABINE 960
12516 1                   EFAVIRENZ//NEVIRAPINE//CYP2B6 900
30421 1                   NELFINAVIR//SAQUINAVIR NO//BECN1 PTDINS3K COMPLEX 169

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 EFAVIRENZ authKW 482345 3% 57% 342
2 NEVIRAPINE authKW 407599 3% 52% 317
3 RALTEGRAVIR authKW 341057 2% 66% 207
4 HIV 1 PROTEASE authKW 315368 2% 60% 212
5 RITONAVIR authKW 314322 2% 47% 268
6 DARUNAVIR authKW 277670 1% 71% 158
7 ATAZANAVIR authKW 244928 1% 65% 152
8 ZIDOVUDINE authKW 239782 3% 31% 312
9 LOPINAVIR authKW 237089 1% 57% 167
10 ANTIVIRAL THERAPY journal 226693 3% 22% 413

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 Infectious Diseases 169266 35% 2% 4297
2 Virology 105787 23% 2% 2762
3 Pharmacology & Pharmacy 32878 31% 0% 3845
4 Immunology 24780 23% 0% 2777
5 Microbiology 15382 16% 0% 1944
6 Chemistry, Medicinal 3455 6% 0% 698
7 Biochemical Research Methods 2243 5% 0% 666
8 Chemistry, Analytical 995 5% 0% 662
9 Biochemistry & Molecular Biology 573 11% 0% 1297
10 Medical Laboratory Technology 480 1% 0% 159

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 AIDS 97333 4% 9% 440
2 INFECT DIS 78148 13% 2% 1566
3 EXPT RETROVIROL SECT 64199 0% 44% 59
4 HIV UNIT 58743 1% 25% 94
5 ST STEPHENS 40620 1% 24% 68
6 VIROL 37780 6% 2% 718
7 IRSICAIXA FDN 34624 0% 35% 40
8 EA 2968 32311 0% 62% 21
9 HIV AIDS MALIGNANCY BRANCH 31006 1% 20% 63
10 INT CLIN VIROL 27133 0% 78% 14

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 ANTIVIRAL THERAPY 226693 3% 22% 413
2 AIDS 125939 5% 8% 661
3 AIDS RESEARCH AND HUMAN RETROVIRUSES 84523 3% 8% 427
4 JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES 67493 3% 8% 339
5 HIV CLINICAL TRIALS 67467 1% 23% 118
6 HIV MEDICINE 60419 1% 15% 163
7 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 45985 5% 3% 666
8 AIDS REVIEWS 40289 1% 24% 67
9 JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 26230 3% 3% 366
10 JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES 14968 1% 6% 103

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 EFAVIRENZ 482345 3% 57% 342 Search EFAVIRENZ Search EFAVIRENZ
2 NEVIRAPINE 407599 3% 52% 317 Search NEVIRAPINE Search NEVIRAPINE
3 RALTEGRAVIR 341057 2% 66% 207 Search RALTEGRAVIR Search RALTEGRAVIR
4 HIV 1 PROTEASE 315368 2% 60% 212 Search HIV+1+PROTEASE Search HIV+1+PROTEASE
5 RITONAVIR 314322 2% 47% 268 Search RITONAVIR Search RITONAVIR
6 DARUNAVIR 277670 1% 71% 158 Search DARUNAVIR Search DARUNAVIR
7 ATAZANAVIR 244928 1% 65% 152 Search ATAZANAVIR Search ATAZANAVIR
8 ZIDOVUDINE 239782 3% 31% 312 Search ZIDOVUDINE Search ZIDOVUDINE
9 LOPINAVIR 237089 1% 57% 167 Search LOPINAVIR Search LOPINAVIR
10 SAQUINAVIR 218788 1% 57% 154 Search SAQUINAVIR Search SAQUINAVIR

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 SHAFER, RW , (2002) GENOTYPIC TESTING FOR HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 DRUG RESISTANCE.CLINICAL MICROBIOLOGY REVIEWS. VOL. 15. ISSUE 2. P. 247 -+ 270 77% 185
2 FRENTZ, D , BOUCHER, CAB , VAN DE VIJVER, DAMC , (2012) TEMPORAL CHANGES IN THE EPIDEMIOLOGY OF TRANSMISSION OF DRUG-RESISTANT HIV-1 ACROSS THE WORLD.AIDS REVIEWS. VOL. 14. ISSUE 1. P. 17 -27 170 79% 77
3 GHOSH, AK , OSSWALD, HL , PRATO, G , (2016) RECENT PROGRESS IN THE DEVELOPMENT OF HIV-1 PROTEASE INHIBITORS FOR THE TREATMENT OF HIV/AIDS.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 59. ISSUE 11. P. 5172 -5208 144 80% 6
4 SHAFER, RW , SCHAPIRO, JM , (2008) HIV-1 DRUG RESISTANCE MUTATIONS: AN UPDATED FRAMEWORK FOR THE SECOND DECADE OF HAART.AIDS REVIEWS. VOL. 10. ISSUE 2. P. 67 -84 183 66% 166
5 CLUTTER, DS , JORDAN, MR , BERTAGNOLIO, S , SHAFER, RW , (2016) HIV-1 DRUG RESISTANCE AND RESISTANCE TESTING.INFECTION GENETICS AND EVOLUTION. VOL. 46. ISSUE . P. 292 -307 155 81% 1
6 VANDAMME, AM , CAMACHO, RJ , CECCHERINI-SILBERSTEIN, F , DE LUCA, A , PALMISANO, L , PARASKEVIS, D , PAREDES, R , POLJAK, M , SCHMIT, JC , SORIANO, V , ET AL (2011) EUROPEAN RECOMMENDATIONS FOR THE CLINICAL USE OF HIV DRUG RESISTANCE TESTING: 2011 UPDATE.AIDS REVIEWS. VOL. 13. ISSUE 2. P. 77 -108 163 68% 62
7 WENSING, AMJ , VAN MAARSEVEEN, NM , NIJHUIS, M , (2010) FIFTEEN YEARS OF HIV PROTEASE INHIBITORS: RAISING THE BARRIER TO RESISTANCE.ANTIVIRAL RESEARCH. VOL. 85. ISSUE 1. P. 59-74 118 84% 147
8 HIRSCH, MS , GUNTHARD, HF , SCHAPIRO, JM , BRUN-VEZINET, F , CLOTET, B , HAMMER, SM , JOHNSON, VA , KURITZKES, DR , MELLORS, JW , PILLAY, D , ET AL (2008) ANTIRETROVIRAL DRUG RESISTANCE TESTING IN ADULT HIV-1 INFECTION: 2008 RECOMMENDATIONS OF AN INTERNATIONAL AIDS SOCIETY-USA PANEL.CLINICAL INFECTIOUS DISEASES. VOL. 47. ISSUE 2. P. 266 -285 129 75% 239
9 MENENDEZ-ARIAS, L , (2013) MOLECULAR BASIS OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 DRUG RESISTANCE: OVERVIEW AND RECENT DEVELOPMENTS.ANTIVIRAL RESEARCH. VOL. 98. ISSUE 1. P. 93-120 174 54% 63
10 PAREDES, R , CLOTET, B , (2010) CLINICAL MANAGEMENT OF HIV-1 RESISTANCE.ANTIVIRAL RESEARCH. VOL. 85. ISSUE 1. P. 245-265 136 84% 41

Classes with closest relation at Level 2


Rank Class id link
1 2356 NNRTIS//REVERSE TRANSCRIPTASE//HIV DRUG ISTANCE PROGRAM
2 61 HIV//AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV//ANTIRETROVIRAL THERAPY
3 2828 HIV ASSOCIATED NEPHROPATHY//TENOFOVIR//HIVAN
4 571 LIPODYSTROPHY//HIV//JOURNAL OF NEUROVIROLOGY
5 10 AIDS RESEARCH AND HUMAN RETROVIRUSES//VIROLOGY//HIV 1
6 1825 INTEGRASE//VPR//APOBEC3G
7 793 NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS//NUCLEOSIDES//CARBOCYCLIC NUCLEOSIDES
8 1695 BACTERIAL VAGINOSIS//MICROBICIDE//GARDNERELLA VAGINALIS
9 1155 PEPT1//ORGANIC CATION TRANSPORTER//OATP1B1
10 2486 PYRAZINAMIDE//ISONIAZID//RIFAMPICIN

Go to start page